Pharmacovigilance of carmustine: distinct neurotoxic and systemic safety signals identified in FAERS
Kaizhi Xu, Meixuan Guo, Huqiang Dong, Mengyuan Cai, Ping Xu · 2026
Read Pharmacovigilance of carmustine: distinct neurotoxic and systemic safety signals identified in FAERS by Kaizhi Xu, Meixuan Guo, Huqiang Dong, Mengyuan Cai, Ping Xu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13474793.txt.
Description
Xu and colleagues mined United States drug safety reports in 2026 for side effects linked to carmustine, a chemotherapy drug used for brain tumors, lymphomas, and stem cell transplant preparation. They pulled every report naming carmustine as the prime suspect from the FDA Adverse Event Reporting System between 2004 and 2024. Statistical signal tests then flagged which problems appeared more often than expected for this drug.
The search covered 718 reports holding 3,091 coded side effect terms, and the strongest signals grouped around the nervous system, blood, and infections in those reports. Rare brain-related terms stood out, including eosinophilic meningitis, air trapped inside the skull, and low pressure inside the skull after treatment with the drug. Reporting patterns also differed by sex, so the authors urge continued monitoring rather than firm claims about cause and effect from these data.
Catalog record
| CREATOR | Kaizhi Xu, Meixuan Guo, Huqiang Dong, Mengyuan Cai, Ping Xu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 55 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |